Intrauterine growth retardation: etiology, Ultrasound diagnosis, management.

Se realiza el estudio” Demanda y oferta de la atención del aborto incompleto en el Hospital Goyeneche de Arequipa. 2005 “con los siguientes objetivos: 1) determinar la característica de la demanda de la atención del aborto incompleto en el Hospital Goyeneche (HG) 2) Precisar las características de la oferta de la atención del aborto incompleto en el HG 3) Relacionar la demanda y la oferta de la atención del aborto incompleto en el HG. La Hipótesis planteada es :” Dado que la salud reproductiva significa un equilibrio con su entorno ecológico, político y social , para el desarrollo sostenido y sustentable, cuya ruptura ocasiona morbimortalidad materna , la cual se ve incrementada por situaciones imprevistas como el aborto; y quién padece esta situación vive una problemática compleja, no solo médica sino social, y acuden a los hospitales , para ser atendidas , solo cuand...

Objetive: a) To determine residual estrogen plasma levels seven days after conclusion of estrogen administration in postmenopausal women. b) To confirm if there is any difference in plasma levels between oral (0, 625mg conjugated estrogen) and transdermal (50 mg 17 beta estradiol) administration. c) To assess the clinical impact of residual plasma levels with the Blatt Kupperman Postmenopausal Index (BKMI). MATERIAL AND METHODS: Measurements of estrogen plasma levels were done previous to treatment, and in the seventh day following two or four months treatment with oral and transdermal administration. Symptoms were assessed in each three instances. RESULTS: Estrogen plasma levels remain above basal levels aftertwo and fourmonths treatment. The BKMI decreases 70% independently of estrogen plasma levels and route of administration. Conclusions: Estrogen plasma levels remain above basal lev...

Objetive: a) To determine residual estrogen plasma levels seven days after conclusion of estrogen administration in postmenopausal women. b) To confirm if there is any difference in plasma levels between oral (0, 625mg conjugated estrogen) and transdermal (50 mg 17 beta estradiol) administration. c) To assess the clinical impact of residual plasma levels with the Blatt Kupperman Postmenopausal Index (BKMI). MATERIAL AND METHODS: Measurements of estrogen plasma levels were done previous to treatment, and in the seventh day following two or four months treatment with oral and transdermal administration. Symptoms were assessed in each three instances. RESULTS: Estrogen plasma levels remain above basal levels aftertwo and fourmonths treatment. The BKMI decreases 70% independently of estrogen plasma levels and route of administration. Conclusions: Estrogen plasma levels remain above basal lev...